What is the price target for NICE stock?
16 analysts have analysed NICE and the average price target is 186.37 USD. This implies a price increase of 64.05% is expected in the next year compared to the current price of 113.61.
NICE LTD - SPON ADR (NICE) Forecast, Price Target & Analyst Ratings
NASDAQ:NICE • US6536561086
Current stock price
113.61 USD
+0.41 (+0.36%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NICE LTD - SPON ADR (NICE).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 13, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $2.63
- Revenue Estimate
- 776.48M
Price Target Details & History
Consensus Price Target and Range
Mean target
$186.37
Upside
+ 64.05%
From current price of $113.61 to mean target of $186.37, Based on 16 analyst forecasts
Low
$184.55
Median
$186.37
High
$191.85
Price Target Revisions
1 Month
0.00%
3 Months
-6.95%
Price Target Summary
16 Wall Street analysts provided a forecast for the next 12 months for NICE. The average price target is 186.37 USD. This implies a price increase of 64.05% is expected in the next year compared to the current price of 113.61.
The average price target has been revised downward by 6.95% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
77.50%
NICE was analyzed by 16 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about NICE.
In the previous month the buy percentage consensus was at a similar level.
NICE was analyzed by 16 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-20 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-02-20 | Rosenblatt | Maintains | Buy -> Buy |
| 2026-02-20 | Wedbush | Reiterate | Neutral -> Neutral |
| 2025-12-23 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-12-08 | Wedbush | Downgrade | Outperform -> Neutral |
| 2025-11-19 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-19 | Citigroup | Maintains | Buy -> Buy |
| 2025-11-18 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2025-11-18 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-11-18 | DA Davidson | Maintains | Neutral -> Neutral |
| 2025-11-18 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-18 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-11-18 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-11-18 | Jefferies | Maintains | Hold -> Hold |
| 2025-11-14 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-14 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-13 | Jefferies | Reiterate | Hold |
| 2025-08-26 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-08-15 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-08-15 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-14 | DA Davidson | Maintains | Neutral -> Neutral |
| 2025-07-29 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-06-20 | DA Davidson | Maintains | Buy -> Buy |
| 2025-06-20 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-06-18 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 13, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $2.63
- Revenue Estimate
- 776.48M
- Revenue Q2Q
- 10.90%
- EPS Q2Q
- -9.70%
- Number of Analysts
- 12
Next Earnings Revisions
Revenue (1 Month)
-0.05%
Revenue (3 Months)
-0.03%
EPS (1 Month)
0.00%
EPS (3 Months)
-4.67%
Next Earnings Summary
NICE is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is 2.63 USD and the consensus revenue estimate is 776.48M USD.
The next earnings revenue estimate has been revised downward by 0.03% in the past 3 months.
Full Analyst Estimates 2026 - 2028
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.378B 9.00% | 2.735B 15.05% | 2.945B 7.68% | 3.244B 10.14% | 3.556B 9.62% | 4.008B 12.71% | |
| EBITDA YoY % growth | 616.574M 20.48% | 754.141M 22.31% | 853.868M 13.22% | 972.95M 13.95% | 1.025B 5.35% | 1.242B 21.17% | |
| EBIT YoY % growth | 449.214M 34.01% | 549.121M 22.24% | 654.824M 19.25% | 836.09M 27.68% | 937.82M 12.17% | 1.092B 16.44% | |
| Operating Margin | 18.89% | 20.08% | 22.23% | 25.77% | 26.37% | 27.25% | |
| EPS YoY % growth | 8.91 15.34% | 11.27 26.51% | 12.47 10.61% | 11.34 -9.00% | 12.83 13.14% | 15.73 22.57% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.63 -9.70% | 2.75 -9.78% | 2.86 -11.14% | 3.12 -5.07% | 2.95 12.37% | 3.08 11.87% | 3.22 12.44% | 3.49 11.86% | 3.47 17.64% | 3.68 19.67% | 3.94 22.36% | 4.33 24.26% |
| Revenue Q2Q % growth | 776.48M 10.90% | 793.19M 9.15% | 810.4M 10.71% | 865.67M 10.07% | 847.06M 9.09% | 865.63M 9.13% | 885.38M 9.25% | 946.38M 9.32% | 948.86M 12.02% | 974.13M 12.53% | 1.004B 13.40% | 1.075B 13.59% |
| EBITDA Q2Q % growth | 223.37M 16.34% | 237.18M -4.61% | 246.43M -19.58% | 265.89M -29.15% | 244.15M 9.30% | 239.32M 0.90% | 245.99M -0.18% | 261.55M -1.63% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 194.21M 30.72% | 202.77M 26.26% | 211.2M 24.64% | 228.49M 29.65% | 216.96M 11.71% | 225.73M 11.32% | 235.66M 11.58% | 255.88M 11.99% | 247.16M 13.92% | 260.24M 15.29% | 277.45M 17.73% | 298.9M 16.81% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
8.06%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
10.17%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
10.36%
EBIT Next 5 Year
N/A
NICE LTD - SPON ADR / NICE Forecast FAQ
When does NICE LTD - SPON ADR (NICE) report earnings?
NICE LTD - SPON ADR (NICE) will report earnings on 2026-05-13, before the market open.
What are the consensus estimates for NICE stock next earnings?
The consensus EPS estimate for the next earnings of NICE LTD - SPON ADR (NICE) is 2.63 USD and the consensus revenue estimate is 776.48M USD.
What is the consensus rating for NICE stock?
The consensus rating for NICE LTD - SPON ADR (NICE) is 77.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.